Articles with public access mandates - Mathieu P RoderoLearn more
Not available anywhere: 9
Human Disease Phenotypes Associated With Mutations in TREX1
GI Rice, MP Rodero, YJ Crow
Journal of clinical immunology 35 (3), 235-243, 2015
Mandates: European Commission
Myogenic progenitor cells exhibit IFN type I-driven pro-angiogenic properties and molecular signature during juvenile dermatomyositis
C Gitiaux, C Latroche, M Weiss-Gayet, M Rodero, D Duffy, BB Meunier, ...
Neuromuscular Disorders 27, S155-S156, 2017
Mandates: National Institute of Health and Medical Research, France
Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood …
ML Fremond, C Uggenti, LE Van, I Melki, V Bondet, N Kitabayashi, ...
Arthritis & rheumatology (Hoboken, NJ) 69 (7), 1495-1501, 2017
Mandates: National Institute of Health and Medical Research, France, European Commission
Circulating interferon‐α measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity
I Melki, H Devilliers, C Gitiaux, V Bondet, A Belot, C Bodemer, P Quartier, ...
Arthritis & Rheumatology, 2019
Mandates: National Institute of Health and Medical Research, France, Agence Nationale …
Expanding the clinical spectrum of Fowler syndrome: three siblings with survival into adulthood and systematic review of the literature
C De Luca, YJ Crow, M Rodero, GI Rice, M Ahmed, M Lammens, ...
Clinical Genetics, 2020
Mandates: Agence Nationale de la Recherche
Biallelic Mutations in MTPAP Associated with a Lethal Encephalopathy
L Van Eyck, F Bruni, A Ronan, TA Briggs, T Roscioli, GI Rice, G Vassallo, ...
Neuropediatrics, 2019
Mandates: Research Foundation (Flanders), UK Medical Research Council, National …
IFN-β plasmatic levels are best predictors of muscle disease activity than IFN-α in a longitudinal cohort of patients with juvenile dermatomyositis
TRJ Moreau, V Bondet, J Ramos, N Ouldali, MA Alyanakian, C Bodemer, ...
Mandates: Agence Nationale de la Recherche
Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?
B Bader-Meunier, S Breton, D Duffy, C Gitiaux, P Quartier, I Lemelle, ...
Rheumatology (Oxford, England), keac696, 2023
Mandates: Agence Nationale de la Recherche
pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma
SX Tan, S Chong, C Rowe, M Claeson, J Dight, C Zhou, MP Rodero, ...
Melanoma Research, 10.1097, 2023
Mandates: National Health and Medical Research Council, Australia
Available somewhere: 57
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
C Combadière, S Potteaux, M Rodero, T Simon, A Pezard, B Esposito, ...
Circulation 117 (13), 1649-1657, 2008
Mandates: National Institute of Health and Medical Research, France
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science Immunology 6 (62), eabl4340, 2021
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, National …
Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
MP Rodero, YJ Crow
Journal of Experimental Medicine, jem. 20161596, 2016
Mandates: UK Medical Research Council, European Commission
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science Immunology 6 (62), eabl4348, 2021
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, National …
Detection of interferon alpha protein reveals differential levels and cellular sources in disease
MP Rodero, J Decalf, V Bondet, D Hunt, GI Rice, S Werneke, ...
Journal of Experimental Medicine, jem. 20161451, 2017
Mandates: Cancer Research UK, Wellcome Trust, European Commission
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children
ML Frémond, MP Rodero, N Jeremiah, A Belot, E Jeziorski, D Duffy, ...
Journal of Allergy and Clinical Immunology 138 (6), 1752-1755, 2016
Mandates: National Institute of Health and Medical Research, France, European Commission
Type I interferon-mediated autoinflammation due to DNase II deficiency
MP Rodero, A Tesser, E Bartok, GI Rice, E Della Mina, M Depp, B Beitz, ...
Nature Communications 8 (1), 2176, 2017
Mandates: German Research Foundation, National Institute of Health and Medical …
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
L Ladislau, X Suárez-Calvet, S Toquet, O Landon-Cardinal, D Amelin, ...
Brain, 2018
Mandates: National Institute of Health and Medical Research, France, Government of Spain
Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency
N Hernandez, I Melki, H Jing, T Habib, SSY Huang, J Danielson, T Kula, ...
Journal of Experimental Medicine, jem. 20180628, 2018
Mandates: US National Institutes of Health, National Institute of Health and Medical …
Assessment of type I interferon signaling in pediatric inflammatory disease
GI Rice, I Melki, ML Frémond, TA Briggs, MP Rodero, N Kitabayashi, ...
Journal of clinical immunology 37 (2), 123-132, 2017
Mandates: National Institute of Health and Medical Research, France, Versus Arthritis …
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
I Melki, Y Rose, C Uggenti, L Van Eyck, ML Frémond, N Kitabayashi, ...
Journal of Allergy and Clinical Immunology, 2017
Mandates: Research Foundation (Flanders), Fondazione Telethon, Italy, European Commission
Publication and funding information is determined automatically by a computer program